OraSure Technologies Inc

$ 4.09

-4.88%

01 Jun - close price

  • Market Cap 281,591,000 USD
  • Current Price $ 4.09
  • High / Low $ 4.29 / 4.03
  • Stock P/E N/A
  • Book Value 4.84
  • EPS -1.05
  • Next Earning Report 2026-08-04
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.11 %
  • ROE -0.21 %
  • 52 Week High 4.33
  • 52 Week Low 2.08

About

OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.

Analyst Target Price

$4.75

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-062026-02-252025-11-052025-08-052025-05-072025-02-252024-11-062024-08-062024-05-082024-02-272023-11-072023-08-03
Reported EPS -0.24-0.19-0.13-0.19-0.18-0.06-0.010.070.040.270.270.09
Estimated EPS -0.17-0.19-0.15-0.15-0.12-0.0107-0.020.030.030.090.08-0.08
Surprise -0.0700.02-0.04-0.06-0.04930.010.040.010.180.190.17
Surprise Percentage -41.1765%0%13.3333%-26.6667%-50%-460.7477%50%133.3333%33.3333%200%237.5%212.5%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-04
Fiscal Date Ending 2026-06-30
Estimated EPS -0.18
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: OSUR

...
OraSure Technologies, Inc. - Common Stock (NQ: OSUR)

2026-05-29 02:10:01

This article provides a list of recent news and financial updates concerning OraSure Technologies, Inc. (OSUR) stock. It includes announcements of earnings calls, quarterly financial results, strategic distribution agreements, and appearances at investor conferences, along with mentions in various financial news outlets regarding stock performance and analyst ratings.

...
OraSure Technologies Hits New 52-Week High at $4.00

2026-05-29 01:40:15

OraSure Technologies, a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week high of $4.00, marking a significant increase from its previous low of $2.08. Despite this stock performance, the company faces financial challenges, including a negative return on equity and a lack of dividend yield. This movement highlights the stock's volatility within the microcap market, with observers watching how these trends develop given the company's financial standing.

...
OraSure Technologies Independent Director Acquires 195% More Stock

2026-05-17 12:40:30

OraSure Technologies (NASDAQ:OSUR) Independent Director, Steven Boyd, recently purchased US$225k worth of the company's stock at US$3.00 per share, increasing his holding by 195%. This significant insider purchase suggests optimism despite the company not making a profit in the last year. The article highlights that insiders owning 6.1% of the company indicates a reasonable degree of alignment with shareholders and a potential belief that the share price is undervalued.

OraSure Technologies (OSUR) price target increased by 25.00% to 5.10

2026-05-16 21:10:23

The article reports that the price target for OraSure Technologies (OSUR) has been increased by 25% to $5.10. This indicates a revised outlook for the company's stock by analysts.

...
OraSure director Steven Boyd purchases $224,750 in stock

2026-05-15 20:38:56

OraSure Technologies Inc. director Steven Boyd recently acquired 75,000 shares of the company's common stock over three days, totaling $224,750. These purchases, made at prices between $2.98 and $3.02 per share, increased his direct ownership to 113,462 shares. The transactions occurred after OraSure's stock gained 28% in six months, despite a recent Q1 2026 earnings and revenue miss.

OraSure (OSUR) director has 21,305 shares withheld to cover tax on vested stock

2026-05-15 10:42:57

OraSure Technologies director Nancy J. Gagliano reported a tax-related share disposition. On May 13, 2026, 21,305 shares of common stock were withheld at $3.02 per share to cover tax liabilities associated with the vesting of restricted shares. After this transaction, Ms. Gagliano directly holds 138,949 OraSure common shares.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi